DRW Securities’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-515
Closed -$128K 154
2018
Q1
$128K Hold
515
0.01% 116
2017
Q4
$70K Buy
+515
New +$70K 0.01% 419